|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Amyloid Beta (1-42) ELISA Assay | Anti-Tocilizumab (Actemra®) ELISA | Bevacizumab (Avastin®) ELISA | Endothelial Lipase (EL) C-Terminal ELISA | Syndecan ELISA Assay |
| Citations | | | | | |
| Catalog Number | 27711 | TM09021 | TM09010 | 27263 | 27188 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Solid phase sandwich ELISA for the determination of human Aß(1-42) in cerebrospinal fluid, cell culture media or the extract from brain tissue. For research use only, not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) test kit for the determination of free antibodies directed against the drug Tocilizumab (Actemra®) in serum and plasma. For research use only, not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) test kit for the determination of free antibodies directed against the drug Bevacizumab (Avastin®) in serum and plasma. For research use only, not for use in diagnostic procedures. | Solid phase sandwich enzyme-linked immunosorbent assay (ELISA) for the determination of Endothelial Lipase (EL) C-Terminal in human serum and EDTA-plasma. For research use only, not for use in diagnostic procedures. | Solid phase sandwich ELISA for the determination of Human Syndecan-4 in serum, EDTA plasma and cell culture supernatant. For research use only, not for use in diagnostic procedures. |
| Detection Target | Anti-Infliximab (Remicade®, Remsima®, and Inflectra®) (ATI) | S100B | Bevacizumab (Avastin®) | Noradrenaline | Angiotensinogen (Intact) |
| Sample Type | Serum and plasma. | Serum | Serum and plasma. | Multiple | Serum, EDTA plasma, and urine. |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | 12.5 to 800 pg/mL | 0 / 6 to 200 ng/mL | 0 / 6 to 200 ng/mL | 0 / 0.13 to 8 ng/mL | 20 to 1280 pg/mL |
| Sensitivity | 1 ng/mL | Inquire | 2 ng/mL | 0.1 ng/mL x Correction Factor (please see protocol) | 0.093 ng/mL |
| Assay Time | Overnight + 1 hr 30 mins (incubation) | 2 hours, 10 min. total incubation time. | 1 hour, 45 min. total incubation time. | Overnight + 30 min. (incubation) | 2 hrs (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |